Cite
Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study
MLA
Wachtell, Kristian, et al. “Relation of Impaired Left Ventricular Filling to Systolic Midwall Mechanics in Hypertensive Patients with Normal Left Ventricular Systolic Chamber Function: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study.” American Heart Journal, vol. 148, no. 3, Sept. 2004, p. 538. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.133045064&authtype=sso&custid=ns315887.
APA
Wachtell, K., Papademetriou, V., Smith, G., Gerdts, E., Dahlof, B., Engblom, E., Aurigemma, G. P., Bella, J. N., Ibsen, H., Rokkedal, J., & Devereux, R. B. (2004). Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study. American Heart Journal, 148(3), 538.
Chicago
Wachtell, Kristian, Vasilios Papademetriou, Gunnar Smith, Eva Gerdts, Bjorn Dahlof, Erik Engblom, Gerard P. Aurigemma, et al. 2004. “Relation of Impaired Left Ventricular Filling to Systolic Midwall Mechanics in Hypertensive Patients with Normal Left Ventricular Systolic Chamber Function: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study.” American Heart Journal 148 (3): 538. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.133045064&authtype=sso&custid=ns315887.